首页> 美国卫生研究院文献>other >Gamete derivation from embryonic stem cells induced pluripotent stem cells or somatic cell nuclear transfer-derived embryonic stem cells: state of the art
【2h】

Gamete derivation from embryonic stem cells induced pluripotent stem cells or somatic cell nuclear transfer-derived embryonic stem cells: state of the art

机译:源自胚胎干细胞诱导多能干细胞或体细胞核移植的胚胎干细胞的配子:最新技术

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Generating gametes from pluripotent stem cells (PSCs) has many scientific justifications and several biomedical rationales. Here, we consider several strategies for deriving gametes from PSCs from mice and primates (human and non-human) and their anticipated strengths, challenges and limitations. Although the ‘Weismann barrier’, which separates the mortal somatic cell lineages from the potentially immortal germline, has long existed, breakthroughs first in mice and now in humans are artificially creating germ cells from somatic cells. Spermatozoa with full reproductive viability establishing multiple generations of seemingly normal offspring have been reported in mice and, in humans, haploid spermatids with correct parent-of-origin imprints have been obtained. Similar progress with making oocytes has been published using mouse PSCs differentiated in vitro into primordial germ cells, which are then cultured after xenografting reconstructed artificial ovaries. Progress in making human oocytes artificially is proving challenging. The usefulness of these artificial gametes, from assessing environmental exposure toxicity to optimising medical treatments to prevent negative off-target effects on fertility, may prove invaluable, as may basic discoveries on the fundamental mechanisms of gametogenesis.
机译:从多能干细胞(PSC)生成配子具有许多科学依据和一些生物医学原理。在这里,我们考虑了从小鼠和灵长类动物(人类和非人类)的PSC中获得配子的几种策略,以及它们的预期优势,挑战和局限性。尽管“ Weismann屏障”将致命的体细胞谱系与潜在的永生种系分离开来,但它早已存在,但首先在小鼠中取得突破,现在人类正在从体细胞中人工创建生殖细胞。在小鼠中已经报道了具有完全生殖能力的精子,其建立了看似正常的后代的多代人,并且在人类中,已经获得了具有正确的母体印记的单倍体精子。使用体外分化为原始生殖细胞的小鼠PSC,已经发表了制备卵母细胞的类似进展,然后在异种移植重建的人工卵巢后进行培养。人工制造人类卵母细胞的进展证明具有挑战性。这些人造配子的有用性,从评估环境暴露的毒性到优化药物治疗以防止对生育力的负面脱靶效应,可能是无价之宝,同时也有关于配子发生基本机制的基本发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号